Palmitic and oleic acid: The Yin and Yang of fatty acids in type 2 diabetes mellitus

Publication date

2020-05-14T08:55:38Z

2020-05-14T08:55:38Z

2018-03-01

2020-05-14T08:55:38Z

Abstract

Increased plasma non-esterified fatty acids (NEFAs) link obesity with insulin resistance and type 2 diabetes mellitus (T2DM). However, in contrast to the saturated FA (SFA) palmitic acid, the monounsaturated FA (MUFA) oleic acid elicits beneficial effects on insulin sensitivity, and the dietary palmitic acid:oleic acid ratio impacts diabetes risk in humans. Here we review recent mechanistic insights into the beneficial effects of oleic acid compared with palmitic acid on insulin resistance and T2DM, including its anti-inflammatory actions, and its capacity to inhibit endoplasmic reticulum (ER) stress, prevent attenuation of the insulin signaling pathway, and improve β cell survival. Understanding the molecular mechanisms of the antidiabetic effects of oleic acid may contribute to understanding the benefits of this FA in the prevention or delay of T2DM.

Document Type

Article


Accepted version

Language

English

Publisher

Elsevier Current Trends

Related items

Versió postprint del document publicat a: https://doi.org/10.1016/j.tem.2017.11.009

Trends in Endocrinology and Metabolism, 2018, vol. 29, num. 3, p. 178-190

https://doi.org/10.1016/j.tem.2017.11.009

Recommended citation

This citation was generated automatically.

Rights

cc-by-nc-nd (c) Elsevier Current Trends, 2018

http://creativecommons.org/licenses/by-nc-nd/3.0/es

This item appears in the following Collection(s)